Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Structural and functional analysis of the natural JNK1 inhibitor quercetagetin

Baek, Sohee, Kang, Nam Joo, Popowicz, Grzegorz M., Arciniega, Marcelino, Jung, Sung Keun, Byun, Sanguine, Song, Nu Ry, Heo, Yong-Seok, Kim, Bo Yeon, Lee, Hyong Joo, Holak, Tad A., Augustin, Martin, Bode, Ann M., Huber, Robert, Dong, Zigang and Lee, Ki Won 2013. Structural and functional analysis of the natural JNK1 inhibitor quercetagetin. Journal of Molecular Biology 425 (2) , pp. 411-423. 10.1016/j.jmb.2012.10.019

Full text not available from this repository.

Abstract

c-Jun NH2-terminal kinases (JNKs) and phosphatidylinositol 3-kinase (PI3-K) play critical roles in chronic diseases such as cancer, type II diabetes, and obesity. We describe here the binding of quercetagetin (3,3′,4′,5,6,7-hydroxyflavone), related flavonoids, and SP600125 to JNK1 and PI3-K by ATP-competitive and immobilized metal ion affinity-based fluorescence polarization assays and measure the effect of quercetagetin on JNK1 and PI3-K activities. Quercetagetin attenuated the phosphorylation of c-Jun and AKT, suppressed AP-1 and NF-κB promoter activities, and also reduced cell transformation. It attenuated tumor incidence and reduced tumor volumes in a two-stage skin carcinogenesis mouse model. Our crystallographic structure determination data show that quercetagetin binds to the ATP-binding site of JNK1. Notably, the interaction between Lys55, Asp169, and Glu73 of JNK1 and the catechol moiety of quercetagetin reorients the N-terminal lobe of JNK1, thereby improving compatibility of the ligand with its binding site. The results of a theoretical docking study suggest a binding mode of PI3-K with the hydroxyl groups of the catechol moiety forming hydrogen bonds with the side chains of Asp964 and Asp841 in the p110γ catalytic subunit. These interactions could contribute to the high inhibitory activity of quercetagetin against PI3-K. Our study suggests the potential use of quercetagetin in the prevention or therapy of cancer and other chronic diseases.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Subjects: Q Science > Q Science (General)
Uncontrolled Keywords: JNK1; quercetagetin; PI3-K
Publisher: Elsevier
ISSN: 0022-2836
Last Modified: 24 Jun 2017 09:53
URI: http://orca.cf.ac.uk/id/eprint/41591

Citation Data

Cited 9 times in Google Scholar. View in Google Scholar

Cited 20 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item